Alprazolam XR
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
59762-0068 -
Package NDC
59762-0068-1 -
Application number
NDA021434 -
SPL ID
70f0098e-50b5-4e61-b4e0-141a55d92267 -
SPL set ID
1338d1c9-7c75-42ed-95f3-9eb1b6fc51d3 -
UNII
YU55MQ3IZY -
RxCUI
433798 -
RxCUI
433799 -
RxCUI
433800 -
RxCUI
433801
What the source publishes
- Labeler
- Mylan Pharmaceuticals Inc.
- Active ingredients
- alprazolam
- Form
- TABLET, EXTENDED RELEASE
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA AUTHORIZED GENERIC
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Alprazolam XR",
"splId": "70f0098e-50b5-4e61-b4e0-141a55d92267",
"labels": [
{
"setId": "1338d1c9-7c75-42ed-95f3-9eb1b6fc51d3",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1338d1c9-7c75-42ed-95f3-9eb1b6fc51d3",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=1338d1c9-7c75-42ed-95f3-9eb1b6fc51d3"
}
],
"routes": [
"ORAL"
],
"labeler": "Mylan Pharmaceuticals Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (59762-0068-1)",
"package_ndc": "59762-0068-1",
"identifierStatus": "well-formed",
"marketing_start_date": "20030117"
}
],
"productId": "59762-0068_70f0098e-50b5-4e61-b4e0-141a55d92267",
"useDomain": "unknown",
"dosageForm": "TABLET, EXTENDED RELEASE",
"productNdc": "59762-0068",
"deaSchedule": "CIV",
"genericName": "alprazolam",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "ALPRAZOLAM",
"strength": "3 mg/1"
}
],
"applicationNumber": "NDA021434",
"marketingCategory": "NDA AUTHORIZED GENERIC",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20030117",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175694",
"M0002356"
],
"unii": [
"YU55MQ3IZY"
],
"rxcui": [
"433798",
"433799",
"433800",
"433801"
],
"spl_set_id": [
"1338d1c9-7c75-42ed-95f3-9eb1b6fc51d3"
],
"pharm_class_cs": [
"Benzodiazepines [CS]"
],
"pharm_class_epc": [
"Benzodiazepine [EPC]"
],
"manufacturer_name": [
"Mylan Pharmaceuticals Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:59762-0068_70f0098e-50b5-4e61-b4e0-141a55d92267"